Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 -0.24 (-7.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Total Non-Current Liabilities (2010 - 2026)

Updated

Ernexa Therapeutics' Total Non-Current Liabilities was $3.11 million in Q2 2026, up 2.9% from $3.03 million a year earlier but down 15.4% from the prior quarter.

Analysis

Ernexa Therapeutics (ERNA) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Total Non-Current Liabilities at Ernexa Therapeutics came in at $3.39 million, down 1.9% from FY2024.

  • Total Non-Current Liabilities shows a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $3.46 million in FY2024 (-92.6%), $46.78 million in FY2023 (+375.4%), $9.84 million in FY2022 (+64.7%) and $5.97 million in FY2021 (+14.4%).
  • Quarterly Total Non-Current Liabilities has moved between -$11.5 million (Q3 2021) and $54.93 million (Q2 2024) over five years.
  • Compared with a year earlier, Total Non-Current Liabilities was higher in 1 of the last eight quarters, with an average decline of 54.8%.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q1 2024 (growth of 659.8%); the worst was Q2 2025 (a decline of 94.5%).
  • Per Business Quant data, ERNA's Total Non-Current Liabilities in the three quarters before Q2 2026 was $3.68 million (Q1 2026), $3.39 million (Q4 2025) and $2.49 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Ernexa Therapeutics 3.74 Mn 3.74 Mn - 3.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.11 Mn
Mar 31, 2026 3.68 Mn
Dec 31, 2025 3.39 Mn
Sep 30, 2025 2.49 Mn
Jun 30, 2025 3.03 Mn
Mar 31, 2025 10.90 Mn
Dec 31, 2024 3.46 Mn
Sep 30, 2024 42.65 Mn
Jun 30, 2024 54.93 Mn
Mar 31, 2024 52.88 Mn
Dec 31, 2023 46.78 Mn
Sep 30, 2023 48.52 Mn
Jun 30, 2023 42.90 Mn
Mar 31, 2023 6.96 Mn
Dec 31, 2022 9.84 Mn
Sep 30, 2022 10.42 Mn
Jun 30, 2022 9.60 Mn
Mar 31, 2022 4.75 Mn
Dec 31, 2021 5.97 Mn
Sep 30, 2021 -11.50 Mn
API Access

Ernexa Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ERNA&period=max&api_key=YOUR_API_KEY